Zealand Pharma

Director's Dealing • May 12, 2024

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Adam Steensberg
2.		Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Performance Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Vesting and allocation of Performance Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		657.5	26,058
d)	Aggregated information - Aggregated volume - Price	26,058 DKK 17,133,135
e)	Date of the transaction	12 May 2024
f)	Place of the transaction	Outside trading Venue